Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Boston Scientific stock
Learn how to easily invest in Boston Scientific stock.
Boston Scientific Corp is a medical devices business based in the US. Boston Scientific shares (BSX) are listed on the NYSE and all prices are listed in US Dollars. Boston Scientific employs 41,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Boston Scientific
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BSX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- BSX shares summary
- Compare share dealing platforms
- Is BSX stock a buy or sell?
- Stock performance over time
- Is BSX suitable for ethical investing?
- Are BSX shares over-valued?
- Boston Scientific's financials
- How volatile are BSX shares?
- Does Boston Scientific pay a dividend?
- Have BSX shares ever split?
- Other common questions
Boston Scientific stock price (NYSE: BSX)Use our graph to track the performance of BSX stocks over time.
Boston Scientific shares at a glance
|Latest market close||$38.01|
|52-week range||$34.98 - $47.50|
|50-day moving average||$40.35|
|200-day moving average||$42.30|
|Wall St. target price||$49.82|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.53|
Buy Boston Scientific shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Boston Scientific stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Boston Scientific price performance over time
|1 week (2022-06-24)||-0.03%|
|1 month (2022-06-02)||-6.54%|
|3 months (2022-03-29)||N/A|
|6 months (2021-12-31)||-10.52%|
|1 year (2021-07-02)||-13.46%|
|2 years (2020-07-02)||7.43%|
|3 years (2019-07-02)||42.69|
|5 years (2017-06-30)||37.12%|
Is Boston Scientific stock undervalued or overvalued?
Valuing Boston Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Boston Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Boston Scientific's P/E ratio
Boston Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Boston Scientific shares trade at around 72x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Boston Scientific's PEG ratio
Boston Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.1563. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Boston Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Boston Scientific's EBITDA
Boston Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a Boston Scientific's overall financial performance and is widely used to measure a its profitability.
Boston Scientific financials
|Revenue TTM||$12.2 billion|
|Operating margin TTM||17.47%|
|Gross profit TTM||$8.2 billion|
|Return on assets TTM||4.2%|
|Return on equity TTM||4.99%|
|Market capitalisation||$54.4 billion|
TTM: trailing 12 months
Boston Scientific's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Boston Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Boston Scientific's total ESG risk score
Total ESG risk: 29.23
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Boston Scientific's overall score of 29.23 (as at 12/31/2018) is nothing to write home about – landing it in it in the 57th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Boston Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Boston Scientific's environmental score
Environmental score: 1.51/100
Boston Scientific's social score
Social score: 12.87/100
Boston Scientific's governance score
Governance score: 7.87/100
Boston Scientific's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Boston Scientific scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Boston Scientific hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||29.23|
|Total ESG percentile||56.94|
|Level of controversy||3|
Boston Scientific share dividends
We're not expecting Boston Scientific to pay a dividend over the next 12 months.
Have Boston Scientific's shares ever split?
Boston Scientific's shares were split on a 2:1 basis on 5 November 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Boston Scientific shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Boston Scientific shares which in turn could have impacted Boston Scientific's share price.
Boston Scientific share price volatility
Over the last 12 months, Boston Scientific's shares have ranged in value from as little as $34.98 up to $47.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Boston Scientific's is 0.8172. This would suggest that Boston Scientific's shares are less volatile than average (for this exchange).
Boston Scientific overview
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Boston Scientific in the news
As a Triple Minority, Shae Finally Feels Seen at Boston Scientific
Boston Scientific Announces Conference Call Discussing Second Quarter 2022 Results
Boston Scientific to open Atlanta plant, latest life sciences win
Frequently asked questionsWhat percentage of Boston Scientific is owned by insiders or institutions?
Currently 0.243% of Boston Scientific shares are held by insiders and 93.111% by institutions. How many people work for Boston Scientific?
Latest data suggests 41,000 work at Boston Scientific. When does the fiscal year end for Boston Scientific?
Boston Scientific's fiscal year ends in December. Where is Boston Scientific based?
Boston Scientific's address is: 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 What is Boston Scientific's ISIN number?
Boston Scientific's international securities identification number is: US1011371077 What is Boston Scientific's CUSIP number?
Boston Scientific's Committee on Uniform Securities Identification Procedures number is: 101137107
More guides on Finder
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert